Market Overview

Aducanumab: 2018-2022 Launch Insights - ResearchAndMarkets.com

Share:

The "Aducanumab
- Launch Insight, 2018"
report has been added to ResearchAndMarkets.com's
offering.

This report provides a comprehensive insight about the Aducanumab's
launch. The report covers all the indications for which the Aducanumab
is being developed and also provides the competitive landscape for the
major indications. The report further includes patent details,
forecasted sales till 2022 and post launch market positioning.

The report will provide a clear picture of market positioning of the
upcoming launch of Aducanumab and will also provide the insight about
how Aducanumab will evolve in the market as well as within its
respective class. Report provides detailed information of clinical
trials that have been or are being conducted for this product. Analysis
and Insightful information around the clinical trials is provided by
assessment of the trial results.

Attribute analysis carried out by analysts helps in understanding how
the upcoming launch scores itself in comparison to other competitors
(both marketed and pipeline). The scoring and analysis has been based
upon scrutinizing data from all key clinical trials for the product. A
head to head comparison with marketed products if available is scanned
thoroughly. Further, analyzing data of other competitors with regards to
the product also assists in proper scoring of the product in its space.

Key Features

  • In-depth analysis and insightful information around the clinical
    trials provided by assessment of the trial results. Assisting
    understanding of how upcoming launches can be blockbuster in their
    respective classes
  • Attribute analysis has been done by scrutinizing data from all key
    clinical trials for the products that will enhance assessment of drugs
    through competitive scoring in relation to other competitors (both
    marketed and pipeline)
  • A thorough head to head comparison with marketed products (if
    available) is carried out
  • Product class share evolution has been provided till 2022, providing a
    thorough assessment of how the launch of these products will affect
    the current and future market trends
  • Competitive Landscape Profile of the products assist in identifying
    potential competitors

Key Topics Covered

Report Introduction

Aducanumab Overview

Aducanumab of action

Pre-clinical Characterization

  • Indication 1
  • Indication 2

Clinical Characterization

  • Indication 1
  • Indication 2

Product Developmental Activities

  • Collaboration
  • Mergers & Acquisitions
  • Financing

Aducanumab Market Evolution

Aducanumab Class Share Evolution

Aducanumab Market Positioning

Patent Expiry Analysis

Competitive Landscape for the Aducanumab in major indications

Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5mq73s/aducanumab?w=4

View Comments and Join the Discussion!